0000914190-21-000203.txt : 20210804
0000914190-21-000203.hdr.sgml : 20210804
20210804160534
ACCESSION NUMBER: 0000914190-21-000203
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210802
FILED AS OF DATE: 20210804
DATE AS OF CHANGE: 20210804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bove Mauro
CENTRAL INDEX KEY: 0001396271
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15070
FILM NUMBER: 211143978
MAIL ADDRESS:
STREET 1: C/O REGENERX BIOPHARMACEUTICALS, INC.
STREET 2: 3 BETHESDA METRO CENTER - SUITE 630
CITY: BETHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000707511
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521253406
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15245 SHADY GROVE ROAD
STREET 2: SUITE 470
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-208-9191
MAIL ADDRESS:
STREET 1: 15245 SHADY GROVE ROAD
STREET 2: SUITE 470
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC
DATE OF NAME CHANGE: 19950719
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-08-02
0000707511
REGENERX BIOPHARMACEUTICALS INC
RGRX
0001396271
Bove Mauro
C/O REGENERX BIOPHARMACEUTICALS, INC.
15245 SHADY GROVE ROAD, SUITE 470
ROCKVILLE
MD
20850
1
0
0
0
Stock Option (right to buy)
0.19
2022-02-11
Common Stock
100000
100000
D
Stock Option (right to buy)
0.36
2022-06-30
Common Stock
100000
100000
D
Stock Option (right to buy)
0.64
2023-03-16
Common Stock
100000
100000
D
Stock Option (right to buy)
0.28
2027-09-01
Common Stock
125000
125000
D
Stock Option (right to buy)
0.21
2028-07-17
Common Stock
200000
200000
D
Stock Option (right to buy)
0.21
2029-05-15
Common Stock
200000
200000
D
Stock Option (right to buy)
0.30
2030-06-10
Common Stock
200000
200000
D
Convertible Promissory Note (right to buy)
0.12
2019-02-27
2024-02-27
Common Stock
41667
5000.00
D
Convertible Promissory Note (right to buy)
0.12
2019-05-13
2024-05-13
Common Stock
41667
5000.00
D
Common Stock Warrant (right to buy)
0.18
2019-08-27
2024-02-27
Common Stock
31250
31250
D
Common Stock Warrant (right to buy)
0.18
2019-11-13
2024-05-13
Common Stock
31250
31250
D
Convertible Promissory Note (right to buy)
0.36
2020-10-15
2025-10-15
Common Stock
27840
10000
D
Common Stock Warrant (right to buy)
0.45
2021-04-15
2025-10-15
Common Stock
20880
20880
D
Stock Option (right to buy)
0.28
2021-08-02
4
A
0
240000
0
A
2031-08-02
Common Stock
240000
240000
D
100% vested.
50,000 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22.
50,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.
60,000 shares vest on each of 8/2/21, 8/2/22, 8/2/23 and 8/2/24.
/s/ Andrew Nick as Attorney-in-Fact for Mauro Bove pursuant to Power of Attorney previously filed.
2021-08-04